Typhoid fever surveillance and vaccine use — South-East Asia and Western Pacific regions, 2009–2013

Morbidity and Mortality Weekly Report

Volumn 63, Issue 39, 2014, Pages 855-860

  Date, Kashmira A ^a   Bentsi Enchill, Adwoa D ^b   Fox, Kimberley K ^b   Abeysinghe, Nihal ^b   Mintz, Eric D ^c   Khan, M Imran ^d   Sahastrabuddhe, Sushant ^e   Hyde, Terri B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d SABIN VACCINE INSTITUTE   (United States)

^e International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TYPHOID PARATYPHOID VACCINE;

CHILD; EPIDEMIOLOGY; HEALTH SURVEY; HUMAN; PACIFIC ISLANDS; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; SOUTHEAST ASIA; TYPHOID FEVER;

ASIA, SOUTHEASTERN; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION PROGRAMS; PACIFIC ISLANDS; POPULATION SURVEILLANCE; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES;

EID: 84908025540     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004;82:346-53.
2. Levine MM, Tapia MD, Zaidi AKM. Typhoid and paratyphoid (enteric) fever. Chapter 16. In: Tropical infectious diseases: principles, pathogens and practice. Third ed: Elsevier Inc.; 2011.
3. Crump JA, Mintz ED. Global trends in typhoid and paratyphoid fever. Clin Infect Dis 2010;50:241-6.
4. Parry CM, Wijedoru L, Arjyal A, Baker S. The utility of diagnostic tests for enteric fever in endemic locations. Expert Rev Anti Infect Ther 2011;9:711-25.
5. Scobie HM, Nilles E, Kama M, et al. Impact of a targeted typhoid vaccination campaign following cyclone Tomas, Republic of Fiji, 2010. Am J Trop Med Hyg 2014;90:1031-8.
6. Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 2008;86:260-8.
7. Ochiai RL, Acosta CJ, Agtini M, et al. The use of typhoid vaccines in Asia: the DOMI experience. Clin Infect Dis 2007;45(Suppl 1):S34-8.
8. Mogasale V, Maskery B, Ochiai RL, et al. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Global Health 2014;2:e570-80.
9. Slayton RB, Date KA, Mintz ED. Vaccination for typhoid fever in sub- Saharan Africa. Hum Vaccin Immunother 2013;9:903-6.
10. Khan MI, Ochiai RL, Clemens JD. Population impact of Vi capsular polysaccharide vaccine. Expert Rev Vaccines 2010;9:485-96.